Showing results (61-70 of 86) with videos related to

Sort By:
Pageof 9
British Journal of Cancer|November 26, 2022
Additional consensus recommendations for conducting complex innovative trials of oncology agents: a post-pandemic perspectiveSarah P Blagden, Ly-Mee Yu, Stephanie Ellis, et al.
The Journal of Urology|November 24, 2012
Reproductive potential of men with obstructive azoospermia undergoing percutaneous sperm retrieval and intracytoplasmic sperm injection according to the cause of obstructionSandro C Esteves, Walter Lee, David J Benjamin, et al.
Clinical Lung Cancer|August 4, 2019
A Population-Based Study of Incidence and Survival of 1588 Thymic Malignancies: Results From the California Cancer RegistryDavid J Benjamin, Amy Klapheke, Primo N Lara, et al.
Reproductive Biology and Endocrinology : RB&E|March 24, 2011
Proteomics: a subcellular look at spermatozoaStefan S du Plessis, Anthony H Kashou, David J Benjamin, et al.
Cancer Treatment Reviews|February 25, 2025
Individualizing first-line treatment for advanced urothelial carcinoma: A favorable dilemma for patients and physiciansEnrique Grande, Syed A Hussain, Philippe Barthélémy, et al.
International Journal of Epidemiology|May 17, 2021
Chronic medical conditions and late effects after acute myeloid leukaemia in adolescents and young adults: a population-based studyRenata Abrahão, Jasmine C Huynh, David J Benjamin, et al.
Clinical Medicine Insights. Oncology|June 20, 2025
Evaluating Patient Adherence and Persistence to Tyrosine-Kinase Inhibitors for Metastatic Renal Cell Carcinoma: A Retrospective Analysis of Real-World DataZhaohui Liao Arter, David J Benjamin, Yen Cao, et al.
Cancer Treatment and Research Communications|January 7, 2026
Understanding Patient and Oncologist Preferences in the Management of Metastatic Renal Cell CarcinomaOmid Yazdanpanah, Aditya Mahadevan, David J Benjamin, et al.
NPJ Precision Oncology|January 11, 2025
Comprehensive analysis of targetable mutations and tumor microenvironment in urachal cancerDavid J Benjamin, Tolulope T Adeyelu, Andrew Elliott, et al.
Frontiers in Oncology|March 29, 2021
Outcomes of Adults With Relapsed/Refractory Acute Myeloid Leukemia Treated With Venetoclax Plus Hypomethylating Agents at a Comprehensive Cancer CenterMatthew E Tenold, Benjamin N Moskoff, David J Benjamin, et al.
Pageof 9